Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL): Price and Financial Metrics


Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL): $9.28

-0.72 (-7.20%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AVDL Stock Price Chart Interactive Chart >

Price chart for AVDL

AVDL Price/Volume Stats

Current price $9.28 52-week high $10.02
Prev. close $10.00 52-week low $1.05
Day low $8.81 Volume 957,700
Day high $10.00 Avg. volume 1,535,949
50-day MA $6.57 Dividend yield N/A
200-day MA $5.63 Market Cap 573.31M

Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL) Company Bio


Avadel Pharmaceuticals plc develops and commercializes pharmaceutical products based on its proprietary drug delivery technology for primary care and sterile injectable markets in the United States, France, and Ireland. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. The company was founded in 1990 and is based in Dublin, Ireland.


AVDL Latest News Stream


Event/Time News Detail
Loading, please wait...

AVDL Latest Social Stream


Loading social stream, please wait...

View Full AVDL Social Stream

Latest AVDL News From Around the Web

Below are the latest news stories about AVADEL PHARMACEUTICALS PLC that investors may wish to consider to help them evaluate AVDL as an investment opportunity.

Avadel Pharmaceuticals plc (NASDAQ:AVDL) insiders placed bullish bets worth US$677k in the last 12 months

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Yahoo | November 26, 2022

156K Reasons To Be Bullish On Avadel Pharmaceuticals Stock

Eric J Ende , Director at Avadel Pharmaceuticals (NASDAQ: AVDL ), reported a large insider buy on November 23, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Ende purchased 20,000 shares of Avadel Pharmaceuticals. The total transaction amounted to $156,050. Avadel Pharmaceuticals shares are trading down 2.13% at $7.81 at the time of this writing on Thursday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to … Full story available on Benzinga.com

Benzinga | November 24, 2022

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

DUBLIN, Ireland, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences: Piper Sandler 34th Annual Healthcare Conference: Fireside chat on Tuesday, November 29 at 3:30 p.m. ET.Evercore ISI HealthCONx Conference: Fireside chat on Thursday, December 1 at 2:40 PM ET. A live webcast of these

Yahoo | November 22, 2022

Needham Sticks to Their Buy Rating for Avadel Pharmaceuticals (AVDL)

In a report released today, Ami Fadia from Needham maintained a Buy rating on Avadel Pharmaceuticals (AVDL - Research Report), with a price target of $9.00. The company's shares closed last Friday at $8.03.According to TipRanks, Fadia is a 3-star analyst with an average return of 1.3% and a 47.40% success rate. Fadia covers the Healthcare sector, focusing on stocks such as Biogen, Avadel Pharmaceuticals, and Merus.The word on The Street in general, suggests a Strong Buy analyst consensus rating for Avadel Pharmaceuticals with a $12.60 average price target, a 56.91% upside from current levels. In a report released today, H.C.

Ryan Adist on TipRanks | November 21, 2022

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), 89bio (ETNB) and Avadel Pharmaceuticals (AVDL)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Altimmune (ALT – Research Report), 89bio (ETNB – Research Report) and Avadel Pharmaceuticals (AVDL – Research Report) with bullish sentiments. Altimmune (ALT) In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Altimmune, with a price target of $50.00. The company's shares closed last Friday at $8.84. According to TipRanks.

Christine Brown on TipRanks | November 21, 2022

Read More 'AVDL' Stories Here

AVDL Price Returns

1-mo 57.82%
3-mo 45.23%
6-mo 262.50%
1-year 14.00%
3-year 47.30%
5-year 12.48%
YTD 14.85%
2021 20.96%
2020 -11.52%
2019 192.64%
2018 -68.54%
2017 -21.08%

Continue Researching AVDL

Want to see what other sources are saying about Avadel Pharmaceuticals Plc's financials and stock price? Try the links below:

Avadel Pharmaceuticals Plc (AVDL) Stock Price | Nasdaq
Avadel Pharmaceuticals Plc (AVDL) Stock Quote, History and News - Yahoo Finance
Avadel Pharmaceuticals Plc (AVDL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7021 seconds.